The American Journal of Cardiology

Effect of treatment delay on outcomes in patients with acute myocardial infarction transferred from community hospitals for primary percutaneous coronary intervention
pp. 1243-1247(5)
Authors: Brodie B.R.; Stuckey T.D.; Hansen C.J.; VerSteeg D.; Muncy D.; Pulsipher M.; Gupta N.

Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty
pp. 1248-1252(5)
Authors: Antoniucci D.; Valenti R.; Migliorini A.; Moschi G.; Trapani M.; Buonamici P.; Cerisano G.; Bolognese L.; Santoro G.M.

Intravascular ultrasonic comparisons of mechanisms of vasodilatation of cutting balloon angioplasty versus conventional balloon angioplasty
pp. 1253-1256(4)
Authors: Hara H.; Nakamura M.; Asahara T.; Nishida T.; Yamaguchi T.

Outcome of nonobstructive residual dissections detected by intravascular ultrasound following percutaneous coronary intervention
pp. 1257-1262(6)
Authors: Nishida T.; Colombo A.; Briguori C.; Stankovic G.; Albiero R.; Corvaja N.; Finci L.; Di Mario C.; Tobis J.M.

Effectiveness of three models for comprehensive cardiovascular disease risk reduction
pp. 1263-1268(6)
Authors: Gordon N.F.; English C.D.; Contractor A.S.; Salmon R.D.; Leighton R.F.; Franklin B.A.; Haskell W.L.

One-year outcome after radiofrequency catheter ablation of symptomatic ventricular arrhythmia from right ventricular outflow tract
pp. 1269-1274(6)
Authors: Krittayaphong R.; Sriratanasathavorn C.; Bhuripanyo K.; Raungratanaamporn O.; Soongsawang J.; Khaosa-ard B.; Kangkagate C.

Usefulness of cardiac transplantation in children with visceral heterotaxy (asplenic and polysplenic syndromes and single right-sided spleen with levocardia) and comparison of results with cardiac transplantation in children with dilated cardiomyopathy
pp. 1275-1279(5)
Authors: Larsen R.L.; Eguchi J.H.; Mulla N.F.; Johnston J.K.; Fitts J.; Kuhn M.A.; Razzouk A.J.; Chinnock R.E.; Bailey L.L.

Value of clinical and echocardiographic features in predicting outcome in the fetus, infant, and child with tetralogy of Fallot with absent pulmonary valve complex
pp. 1280-1285(6)
Authors: Moon-Grady A.J.; Tacy T.A.; Brook M.M.; Hanley F.L.; Silverman N.H.

Statins and the soul of medicine
pp. 1286-1290(5)
Author: Ornish D.

Comparison of acute myocardial infarct size in patients =<65 years versus <65 years in the prethrombolytic period versus the thrombolytic period
pp. 1291-1293(3)
Authors: Kloner R.A.; Poole K.; Shook T.; Przyklenk K.; Perritt K.; Cannon C.P.

Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention
pp. 1293-1297(5)
Authors: Herrmann H.C.; Swierkosz T.A.; Kapoor S.; Tardiff D.C.; DiBattiste P.M.; Hirshfeld J.W.; Klugherz B.D.; Kolansky D.M.; Magness K.; Valettas N.; Wilensky R.L.

Effect of coronary stent overexpansion on lumen size and intimal hyperplasia at follow-up
pp. 1297-1299(3)
Authors: Kuriyama N.; Kobayashi Y.; Kuroda N.; Desai K.; Yamamoto Y.; Komiyama N.; Komuro I.; Fitzgerald P.J.

Long-term follow-up of patients with increased cardiac troponin concentrations following percutaneous coronary intervention
pp. 1300-1302(3)
Authors: Wu A.H.B.; Boden W.E.; McKay R.G.

Relation of the pattern of diastolic augmentation during a course of enhanced external counterpulsation (EECP) to clinical benefit (from the International EECP Patient Registry [IEPR])
pp. 1303-1305(3)
Authors: Lakshmi M.V.; Kennard E.D.; Kelsey S.F.; Holubkov R.; Michaels A.D.

Comparison of extended-release niacin and atorvastatin monotherapies and combination treatment of the atherogenic lipid profile in diabetes mellitus
pp. 1306-1308(3)
Authors: Van J.T.; Pan J.; Wasty T.; Chan E.; Wu X.; Charles M.A.

Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose)
pp. 1308-1310(3)
Authors: Alsheikh-Ali A.A.; Abourjaily H.M.; Karas R.H.

Effects of a low-calorie, low-salt diet and treadmill exercise on atherosclerotic risk factors in obese African-American women*
pp. 1311-1313(3)
Authors: Randall O.S.; Feseha H.B.; Retta T.M.; Bettencourt C.N.; Xu S.; Ketete M.; Maqbool A.R.

Association of skin cholesterol content, measured by a noninvasive method, with markers of inflammation and Framingham risk prediction
pp. 1313-1316(4)
Authors: Mancini G.B.J.; Chan S.; Frohlich J.; Kuramoto L.; Schulzer M.; Abbott D.

Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc
pp. 1316-1319(4)
Authors: Bednar M.M.; Harrigan E.P.; Ruskin J.N.

Meta-analysis of nonselective versus beta-1 adrenoceptor-selective blockade in prevention of tilt-induced neurocardiogenic syncope
pp. 1319-1321(3)
Authors: Dendi R.; Goldstein D.S.

Comparison of the beta blocker bucindolol in younger versus older patients with heart failure
pp. 1322-1326(5)
Authors: Aranda J.M.; Krause-Steinrauf H.J.; Greenberg B.H.; Heng M.K.; Kosolcharoen P.K.; Renlund D.G.; Thaneemit-Chen S.; White M.; Cintron G.B.; for the BEST Investigators

Mitral valve prolapse and atrial septal aneurysm: an evaluation in the framingham heart study
pp. 1326-1329(4)
Authors: Freed L.A.; Levy D.; Levine R.A.; Evans J.C.; Larson M.G.; Fuller D.L.; Lehman B.; Benjamin E.J.

Comparison of accuracy of diagnosis of congenital heart disease by history and physical examination versus echocardiography
pp. 1329-1331(3)
Authors: Klewer S.E.; Samson R.A.; Donnerstein R.L.; Lax D.; Zamora R.; Goldberg S.J.

Comparison of reported and expected deaths in sildenafil (Viagra) users
pp. 1331-1334(4)
Authors: Wysowski D.K.; Farinas E.; Swartz L.